Aurelio Miracolo

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Drug Administration

Health Promotion

Top Venues

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Tobias Michaeli, Mackenzie Mills, Thomas Michaeli, Aurelio Miracolo, Panos G Kanavos
Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA. Investigational new drugs 40 (4) (2022)